BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 16332406)

  • 1. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice.
    Clement JG; Shiloff JD; Gennings C
    Arch Toxicol; 1987; 61(1):70-5. PubMed ID: 3326546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HI-6 therapy of soman and tabun poisoning in primates and rodents.
    Hamilton MG; Lundy PM
    Arch Toxicol; 1989; 63(2):144-9. PubMed ID: 2730339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods.
    Kassa J; Cabal J
    Toxicology; 1999 Feb; 132(2-3):111-8. PubMed ID: 10433374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative reactivation efficacy of the oximes HI-6 and HGG-12 in the central nervous system and blood of rats poisoned with nerve gases used in warfare].
    Pantelić D
    God Vojnomed Akad; 1986; 28():35-40. PubMed ID: 3482058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
    Kassa J; Bajgar J
    Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine and oxime treatment in lethal soman poisoning of anaesthetized guinea-pigs: HLö 7 dimethanesulfonate versus HI 6 dichloride.
    Worek F; Szinicz L
    Pharmacol Toxicol; 1993 Jan; 72(1):13-21. PubMed ID: 8441735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
    Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAM-2 Cl, HI-6, and HGG-12 in soman and tabun poisoning.
    Bosković B; Kovacević V; Jovanović D
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S106-15. PubMed ID: 6724203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
    Kassa J
    Ceska Slov Farm; 1999 Jan; 48(1):44-7. PubMed ID: 10376416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of mono- and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice.
    Clement JG
    Fundam Appl Toxicol; 1983; 3(6):533-5. PubMed ID: 6662294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit.
    Koplovitz I; Stewart JR
    Toxicol Lett; 1994 Feb; 70(3):269-79. PubMed ID: 8284794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidotal efficacy of quinuclidinium oximes against soman poisoning.
    Lucić A; Radić B; Peraica M; Mesić M; Primozic I; Binenfeld Z
    Arch Toxicol; 1997; 71(7):467-70. PubMed ID: 9209694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of oxime selection on the efficacy of antidotal treatment of soman-poisoned rats.
    Kassa J; Fusek J
    Acta Medica (Hradec Kralove); 2002; 45(1):19-27. PubMed ID: 12143107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bispyridinium-dioxime HLö-7. A potent reactivator for acetylcholinesterase inhibited by the stereoisomers of tabun and soman.
    de Jong LP; Verhagen MA; Langenberg JP; Hagedorn I; Löffler M
    Biochem Pharmacol; 1989 Feb; 38(4):633-40. PubMed ID: 2917018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of oximes: how relevant are they?
    van Helden HP; Busker RW; Melchers BP; Bruijnzeel PL
    Arch Toxicol; 1996; 70(12):779-86. PubMed ID: 8911635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of several oximes as reactivators of unaged soman-inhibited whole blood acetylcholinesterase in rabbits.
    Harris LW; Anderson DR; Lennox WJ; Woodard CL; Pastelak AM; Vanderpool BA
    Biochem Pharmacol; 1990 Dec; 40(12):2677-82. PubMed ID: 2260991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
    Worek F; Widmann R; Knopff O; Szinicz L
    Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure-activity relationship in reactivators of acetylcholinesterase inhibited by phosphoric esters. XII. Hydroxyiminomethylalkylpyridine iodomethylate].
    Arena F; Luraschi E; Grifantini M; Manna F; Parente G
    Farmaco Sci; 1978 May; 33(5):324-31. PubMed ID: 738450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.